C07C 65/00
Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings
Official title: Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, [IMAGE cpc-sch-C07C-0958.gif] groups, [IMAGE cpc-sch-C07C-0959.gif] groups, or [IMAGE cpc-sch-C07C-0960.gif] groups (cyclic anhydrides C07D)
C07C65/00 (Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings) appears on 1,479 US grants and 943 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,479
- Published applications
- 943
- Assignees
- 731
- Inventors
- 3,382
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 36 | 0 |
| 1977 | 35 | 0 |
| 1978 | 15 | 0 |
| 1979 | 21 | 0 |
| 1980 | 14 | 0 |
| 1981 | 15 | 0 |
| 1982 | 11 | 0 |
| 1983 | 16 | 0 |
| 1984 | 22 | 0 |
| 1985 | 24 | 0 |
| 1986 | 23 | 0 |
| 1987 | 35 | 0 |
| 1988 | 27 | 0 |
| 1989 | 40 | 0 |
| 1990 | 43 | 0 |
| 1991 | 53 | 0 |
| 1992 | 60 | 0 |
| 1993 | 33 | 0 |
| 1994 | 21 | 0 |
| 1995 | 36 | 0 |
| 1996 | 38 | 0 |
| 1997 | 43 | 0 |
| 1998 | 40 | 0 |
| 1999 | 44 | 0 |
| 2000 | 35 | 0 |
| 2001 | 37 | 4 |
| 2002 | 27 | 24 |
| 2003 | 23 | 17 |
| 2004 | 13 | 28 |
| 2005 | 11 | 26 |
| 2006 | 13 | 25 |
| 2007 | 13 | 29 |
| 2008 | 16 | 31 |
| 2009 | 26 | 35 |
| 2010 | 26 | 37 |
| 2011 | 22 | 31 |
| 2012 | 22 | 34 |
| 2013 | 36 | 48 |
| 2014 | 49 | 41 |
| 2015 | 27 | 43 |
| 2016 | 35 | 47 |
| 2017 | 40 | 37 |
| 2018 | 35 | 45 |
| 2019 | 40 | 46 |
| 2020 | 30 | 45 |
| 2021 | 34 | 55 |
| 2022 | 28 | 43 |
| 2023 | 28 | 51 |
| 2024 | 21 | 37 |
| 2025 | 29 | 34 |
| 2026 | 18 | 50 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Salt forms of sabcomeline18 Aug 2026US 12,709,611 B2Syremis Therapeutics, Ltd.
- Onium salt, resist composition, and patterning process4 Aug 2026US 12,699,318 B2Shin-Etsu Chemical Co., Ltd.
- Cocrystalline forms of FGFR3 inhibitors23 Jun 2026US 12,662,483 B2Eli Lilly and Company
- Salt form and crystal form of pyrazole substituted imidazo[1,2-a]quinoxaline derivative9 Jun 2026US 12,649,747 B2Ocumension Therapeutics (Suzhou) Co., Ltd.
- Compound, composition, method for expressing sensitizing effect and production method8 Oct 2026US 2026/0308100 A1Mitsubishi Gas Chemical Company, Inc.
- Cocrystalline forms of fgfr3 inhibitors1 Oct 2026US 2026/0297090 A1Eli Lilly and Company
- Salt form and crystal form of thienopyrimidine compound, and preparation method therefor and use thereof24 Sep 2026US 2026/0285874 A1Shandong Luye Pharmaceutical Co., Ltd.
- Long-chain alkenyloxy-substituted benzoyl derivative and oligonucleotide synthesis method using same17 Sep 2026US 2026/0274885 A1SPERA PHARMA, Inc.
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
Most cited
By later US patents
- Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity167US 5,919,970 AAllergan Sales, Inc. · 1999
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Method of identifying negative hormone and/or antagonist activities151US 5,776,699 AAllergan, Inc. · 1998
- Organometallic fluorenyl compounds, preparation, and use147US 5,436,305 APhillips Petroleum Company · 1995
- Bicyclic naphthalenic derivatives, a process for preparing the same and human or veterinary medicines and cosmetic compositions containing said derivatives142US 4,826,969 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1989